COMPANY · NIPC 502942959

AMGEN BIOFARMACEUTICA, LDA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €340,731,368.07 across 3,306 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameAMGEN BIOFARMACEUTICA, LDA
NIPC502942959
Registered officeAV JOSE MALHOA 19, PISO 5, 1070-040 LISBOA
SourceTED (Jornal Oficial da UE), aviso 652385-2024
Record date28 October 2024

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €8,175,525.9020122013: €8,593,696.902014: €14,020,112.8120142015: €39,028,068.332016: €4,306,419.4920162017: €10,333,078.062018: €9,242,111.1820182019: €17,761,161.712020: €15,583,935.6120202021: €17,113,352.222022: €21,019,985.8220222023: €29,869,8242024: €50,728,960.9220242025: €63,753,455.792026: €31,201,679.332026€63,753,455.79
Contracted value by year
YearContractsContract value
201262€8,175,525.90
2013112€8,593,696.90
201474€14,020,112.81
201584€39,028,068.33
201696€4,306,419.49
2017137€10,333,078.06
2018183€9,242,111.18
2019218€17,761,161.71
2020294€15,583,935.61
2021353€17,113,352.22
2022307€21,019,985.82
2023397€29,869,824
2024416€50,728,960.92
2025330€63,753,455.79
2026243€31,201,679.33
Contracted value by place of performance
NameContractsContract value
Lisboa583€77,257,303.32
Coimbra200€75,887,829.36
Setúbal161€24,588,223.15
Faro165€24,467,740.40
Porto306€20,078,551.64
Évora109€16,121,667.11
Funchal143€13,601,677.25
Almada264€11,784,653.53
Vila Nova de Gaia81€3,727,654.85
Viseu91€3,619,374.64
Largest contracts
SubjectYearContract value
Medicamentos do foro oncológico - com base no CPA 2013/62015€31,589,591.37
41/9041/2025 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/304 - Medicamentos do grupo 4: sangue; 2023/305 - Medicamentos do aparelho cardiovascular; 2023/481 - Medicamentos diversos; 2023/491 - Medicamentos do2025€9,041,417.36
MEDICAMENTOS2025€6,265,021.69
Aquisição de Medicamentos Oncologicos2014€4,443,674.34
41/9028/2024 - Convite à apresentação de propostas ao abrigo dos acordos-quadro: 2021/6 - Medicamentos do foro oncológico e imunomoduladores; 2021/47 - Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormon2024€4,369,492.18

Who they competed with

In 5,814 contracts with a list of competitors, the company took part and was awarded 943 (16%).

Companies with the most procedures in common
CompanyProcedures in common
accord241
pfizer231
generis228
sandoz224
roche188
fresenius184
novartis181
mylan181
alloga166
hikma147
farmoz144
teva Pharma Produtos Farmacêuticos, Lda.136
Abbvie, Lda.117
overpharma111
pharmakern portugal108
Baxter-Médico Farmacêutica, Lda105
Merck, Sharp & Dohme, Lda.93
labesfal90
Medinfar87
janssen84
Zentiva Portugal, Lda.83
sanofi82
Bayer, Lda.76
Biogen Portugal, Lda72
bristol68
lilly64
Astrazeneca-Produtos Farmacêuticos, Lda63
Merck. S.A.59
Krka Farmacêutica, Sociedade Unipessoal, Lda59
medac Sucursal em Portugal53

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents36 companies and 60 links. The list below gives the same content as text.Bayer, Lda. (NIPC 500043256)Bayer, Lda.bristol (NIPC 500048193)bristolnovartis (NIPC 500063524)novartissanofi (NIPC 500134960)sanofipfizer (NIPC 500162166)pfizerlilly (NIPC 500165602)lillyjanssen (NIPC 500189412)janssenMerck, Sharp &… (NIPC 500191360)Merck, Sharp &…roche (NIPC 500233810)rocheMedinfar (NIPC 500384045)MedinfarAMGEN BIOFARMACEUTICA, LDA (NIPC 502942959)AMGEN BIOFARMACEUTICA, LDA+25 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.